Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soliris in CD59 Deficiency
NCT01579838Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Feb 2012
- Primary completion
- Mar 2013
- Countries
- 1
01
Overview
A Phase 2 trial of eculizumab in CD59 deficiency, sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
eculizumab
03
Conditions
CD59 deficiency
Beyond the preview
Go deeper on NCT01579838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579838.